Satoshi Wasamoto

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer

Ou Yamaguchi, Hisao Imai, Hiroyuki Minemura et al. · Cancer Chemotherapy and Pharmacology · 2020 · 47 citations

Geriatric Oncology, Medicine, Immunology +8

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

Hisao Imai, Satoshi Wasamoto, Ou Yamaguchi et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 30 citations · Full text

Geriatric Oncology, Oncology, Elderly Patients +8

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer

Ayako Shiono, Hisao Imai, Satoshi Wasamoto et al. · Cancer Medicine · 2022 · 28 citations · Full text

Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity

Akimasa Sekine, Satoshi Wasamoto, Eri Hagiwara et al. · Respiratory Investigation · 2020 · 14 citations

Obesity, Weight Loss, Advanced Lung Disease +9

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

Hisao Imai, Yoshiaki Nagai, Hiroyuki Minemura et al. · Investigational New Drugs · 2022 · 13 citations · Full text